Cal-Maine Foods (NASDAQ:CALM) reported a sharp decline in second-quarter earnings on Wednesday, January 7, 2026, as the primary U.S. egg producer grapples with a retreat from the record-high commodity prices that fueled prior windfalls.
Net income for the quarter ended November 29, 2025, fell 53.1% to $102.8 million, or $2.13 per diluted share, missing the triple-digit gains seen during the peak of the avian flu supply crunch in fiscal 2025.
Net sales dropped 19.4% to $769.5 million, primarily driven by a 41% plunge in conventional egg revenue.
Despite the top-line pressure, management is aggressively pivoting the company’s portfolio toward higher-margin "value-added" products.
Specialty eggs—including organic, cage-free, and pasture-raised—now account for a record 44% of total shell egg sales, up significantly from a year ago.
The company also announced a $36 million investment to expand its prepared foods capacity by 30%, aiming to capture a larger share of the ready-to-eat protein market through its recently acquired Echo Lake Foods and Crepini brands.
Meanwhile, Cal-Maine remains financially robust, finishing the quarter with zero debt and a strong cash position.
The board declared a cash dividend of $0.72 per share, payable in February, alongside $74.8 million in share repurchases completed during the quarter.
To further bolster its specialty supply chain, the company confirmed the acquisition of Clean Egg production assets, ensuring a steady flow of free-range and cage-free supply as state-level mandates and consumer preferences continue to shift away from caged production.